தரம் கும்பனி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தரம் கும்பனி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தரம் கும்பனி Today - Breaking & Trending Today

Observational Study Supports Continuing Oral Anticoagulation During PCI


April 06, 2021
For patients sent for an unplanned PCI, a strategy of maintaining oral anticoagulation is not associated with a higher risk of ischemic complications or bleeding when compared with a strategy of interrupting the direct oral anticoagulant (DOAC) or vitamin K antagonist (VKA) a day or two before the procedure, a new observational analysis confirms.
Published in the April 12, 2021, issue of
JACC: Cardiovascular Interventions, the study, drawing on the large SWEDEHEART registry, supports the current recommendations from the European Society of Cardiology (ESC) for uninterrupted oral anticoagulation (U-OAC) in patients with atrial fibrillation, venous thromboembolism, or a mechanical heart valve undergoing unplanned, nonemergent PCI, investigators say. ....

United States , Dimitrios Venetsanos , Dharam Kumbhani , Piera Capranzano , Sanjit Jolly , Bayer Janssen , Bristol Myers Squibb , Dominick Angiolillo , Phd University Of Catania , Md Ut Southwestern Medical Center , American College Of Cardiology , Md Mcmaster University Hamilton Health Sciences , Boehringer Ingelheim , Phd Karolinska Institute University Hospital , Phd University Of Florida College Medicine , European Society Of Cardiology , Cardiovascular Interventions , European Society , Karolinska University Hospital , North American , American College , Medical Center , Hamilton Health Sciences , Florida College , ஒன்றுபட்டது மாநிலங்களில் , தரம் கும்பனி ,

Understanding heart disease, stroke in women remains a scientific research priority


 E-Mail
DALLAS, Feb. 15, 2021 Understanding the sex differences in cardiovascular disease presentation and outcomes remains a major research priority demonstrated by the record number of submissions for this year s Go Red for Women® special issue of the American Heart Association s flagship journal
Circulation, published online today.
Circulation editors said more than 100 manuscripts were submitted this year, the most ever in the five years in which the current editorial board has published the special issue.
Undeniably, cardiovascular disease remains the number one killer of women around the world, taking the lives of 1 in 3 women. Even one life lost is too many, because we know much of heart disease and stroke is preventable and treatable, said ....

United States , Bridget Kuehn , Babken Asatryan , Islam Elgendy , Celina Yong , Dharam Kumbhani , Andream Russo , Eloi Marijon , Sederholm Lawesson , Robert Giugliano , Purav Mody , Michelle Odonoghue , Steven Houser , Susan Cheng , Josepha Hill , Malik Elharram , Nosheen Reza , American Heart Association , Ut Southwestern Medical Center , Research For Heart Disease , Harrys Moss Heart Center , Research Goes Red , American Heart Association Scientific Sessions , Go Red Strategically Focused Research Network , Circulation Editor In Chief Joseph , Women Circulation ,

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE


December 22, 2020
Clinicians have a new tool to help them in deciding how best to balance risks and benefits when there’s a need to mix anticoagulation and antiplatelet therapy in patients with A-fib or venous thromboembolism (VTE). It comes in the form of an expert consensus decision pathway from the American College of Cardiology (ACC).
“In general, we have recommended against routine use of triple therapy, which would be [dual antiplatelet therapy (DAPT)] plus anticoagulation,” Dharam Kumbhani, MD (UT Southwestern Medical Center, Dallas, TX), chair of the writing committee, told TCTMD.
Double therapy is the way to go for most cases “based on the concordance of all the data that’s available,” he said, “and several meta-analyses that have looked at that and provided that conclusion.” There are some scenarios when a patient has a high thrombotic risk and low bleeding risk, for example for which physicians may opt for triple therapy for a short duration, ....

United States , Dharam Kumbhani , American Heart Association , Md Ut Southwestern Medical Center , Journal Of The American College Cardiology , American College Of Cardiology , American College , Medical Center , Heart House Roundtables , ஒன்றுபட்டது மாநிலங்களில் , தரம் கும்பனி , அமெரிக்கன் இதயம் சங்கம் , ம்ட் உட் தென்மேற்கு மருத்துவ மையம் , இதழ் ஆஃப் தி அமெரிக்கன் கல்லூரி இருதயவியல் , அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் , அமெரிக்கன் கல்லூரி , மருத்துவ மையம் ,